Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 3 Solid Tumor, Adult 1 Solid Tumor 1 Pancreatic Neoplasms 1 Mesothelioma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Carcinoma, Non-Small-Cell Lung 1 Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation 1 Advanced Solid Tumor 1

Interventions

pembrolizumab 7 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Rosuvastatin Calcium 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 osimertinib 1 niraparib 1 neotil 1 necitumumab 1 mirdametinib 1 leronlimab 1 lenvatinib 1 atezolizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × sotorasib × Other solid neoplasm × Clear all

NCT04092673 2024-05-21

Zotatifin

Effector Therapeutics

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡